Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck

APMIS

Volumn 112, Issue 9, 2004, Pages 560-8

  Eriksen, Jesper Grau ^a   Steiniche, T ^a   Sogaard H ^a   Overgaard, J ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

E cadherin; Grading; Head and neck; Histopathology; Integrins; Squamous cell carcinoma

Indexed keywords

BETA1 INTEGRIN; BETA4 INTEGRIN; BETA6 INTEGRIN; CELL ADHESION MOLECULE; FORMALDEHYDE; INTEGRIN; NIMORAZOLE; PARAFFIN; UVOMORULIN;

ARTICLE; CANCER RADIOTHERAPY; CELL ADHESION; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATINIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MITOSIS; PRIORITY JOURNAL; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

EID: 11144322013     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm1120902.x     Document Type: Article

References (38)

1. Horwitz AF. Integrins and health. Sci Am 1997;276:68-75.
2. Longhurst CM, Jennings LK. Integrin-mediated signal transduction. Cell Mol Life Sci 1998;54:514-26.
3. Thomas GJ, Jones J, Speight PM. Integrins and oral cancer. Oral Oncol 1997;33:381-8.
4. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, et al. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelling. J Cell Sci 1995;108:2241-51.
5. Haapasalmi K, Zhang K, Tonnesen M, Olerud J, Sheppard D, Salo T, et al. Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol 1996;106:42-8.
6. Overgaard J, Alsner J, Eriksen J, Horsman MR, Grau C. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays 2000;25:313-9.
7. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999;5:172-7.
8. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998;186:8-16.
9. Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 2000;6:790-7.
10. Bair EL, Massey CP, Tran NL, Borchers AH, Heimark RL, Cress AE, et al. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001;270:59-67.
11. Ohene-Abuakwa Y, Pignatelli M. Adhesion molecules in cancer biology. Adv Exp Med Biol 2000;465:115-26.
12. Rodrigo JP, Dominguez F, Alvarez C, Manrique C, Herrero A, Suarez C. Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features. Eur J Cancer 2002;38:1059-64.
13. Andrews NA, Jones AS, Helliwell TR, Kinsella AR. Expression of the E-cadherin-catenin cell adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 1997;75:1474-80.
14. Jongen WM, Fitzgerald DJ, Asamoto M, Piccoli C, Slaga TJ, Gros D, et al. Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E- cadherin. J Cell Biol 1991;114:545-55.
15. Hodivala KJ, Watt FM. Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 1994;124:589-600.
16. von Schlippe M, Marshall JF, Perry P, Stone M, Zhu AJ, Hart IR. Functional interaction between E-cadherin and αv-containing integrins in carcinoma cells. J Cell Sci 2000;113:425-37.
17. Danen EH, Sonnenberg A. Erratum: Integrins in regulation of tissue development and function. J Pathol;2003;201:632-41.
18. Regezi JA, Ramos DM, Pytela R, Dekker NP, Jordan RC. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol 2002;38:332-6.
19. Ramos DM, But M, Regezi J, Schmidt BL, Atakilit A, Dang D, et al. Expression of integrin beta6 enhances invasive behaviour in oral squamous cell carcinoma. Matrix Biol 2002;21:297-307.
20. Jones J, Sugiyama M, Watt FM, Speight PM. Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. J Pathol 1993;169:235-43.
21. Larjava H, Lyons JG, Salo T, Makela M, Koivisto L, Birkedal-Hansen H, et al. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol 1993;157:190-200.
22. Day ML, Foster RG, Day KC, Zhao X, Humphrey P, Swanson P, et al. Cell anchorage regulates apoptosis through the retinoblastoma tumour suppressor/E2F pathway. J Biol Chem 1997;272:8125-8.
23. Bachelder RE, Marchetti A, Falcioni R, Soddu S, Mercurio AM. Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J Biol Chem 1999;274:20733-7.
24. Garzino-Demo P, Carrozzo M, Trusolino L, Savoia P, Gandolfo S, Marchisio PC. Altered expression of alpha6 integrin subunit in oral squamous cell carcinoma and oral potentially malignant lesions. Oral Oncol 1998;34:204-10.
25. Downer CS, Watt FM, Speight PM. Loss of alpha6 and beta4 integrin subunits coincides with loss of basement membrane components in oral squamous cell carcinomas. J Pathol 1993;171:83-90.
26. Mainiero F, Pepe A, Yeon M, Ren Y, Giancotti FG. The intracellular functions of α6β4 integrin are regulated by EGF. J Cell Biol 1996;134:241-53.
27. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through upregulation of matrix metalloproteinase-9. Int J Cancer 2001;92:641-50.
28. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999;24:73-6.
29. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987;95:229-49.
30. Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998;46:135-46.
31. Lund C, Sogaard H, Jorgensen K, Elbrond O, Hjelm-Hansen M, Andersen AP. Histological grading of epidermoid carcinomas in the head and neck. Dan Med Bull 1977;24:162-6.
32. Jacobson PA, Eneroth CM, Killander D, Moberger G, Mårtensson B. Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol Ther Phys Biol 1973;12:1-8.
33. Lund C, Sogaard H, Elbrond O, Jorgensen K, Andersen AP. Epidermoid carcinoma of the tongue. Histologic grading in the clinical evaluation. Acta Radiol Ther Phys Biol 1975;14:513-21.
34. Lund C, Sogaard H, Elbrond O, Jorgensen K, Andersen AP. Epidermoid carcinoma of the lip. Histologic grading in the clinical evaluation. Acta Radiol Ther Phys Biol 1975;14:465-74.
35. Miller RT, Kubier P. Blocking of endogenous avidin-binding activity in Immunohistochemistry. The use of egg whites. Appl immunohistochem 1997;5:63-6.
36. Tennenbaum T, Belanger AJ, Quaranta V, Yuspa SH. Differential regulation of integrins and extracellular matrix binding in epidermal differentiation and squamous tumour progression. J Investig Dermatol Symp Proc 1996;1:157-61.
37. Hanby AM, Gillett CE, Pignatelli M, Stamp GW. Beta 1 and beta 4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breast. J Pathol 1993;171:257-62.
38. UICC International Union Against Cancer. Head and neck tumours. In: Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumours. 5 ed. New York: Wiley-Liss; 1997:17-50.